A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia

Journal of Rheumatology

Volumn 32, Issue 7, 2005, Pages 1336-1340

  Finckh, Axel ^a   Berner, Isabelle Carey ^b   Aubry Rozier, Bérengère ^b   So, Alexander Kai Lik ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Complementary therapies; Dehydroepiandrosterone; Fibromyalgia; Randomized controlled trial; Therapy

Indexed keywords

PLACEBO; PRASTERONE;

ACNE; ADRENAL INSUFFICIENCY; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FIBROMYALGIA; FUNCTIONAL DISEASE; GREASY SKIN; HAIR GROWTH; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; SKIN DISEASE; WELLBEING;

AGED; COGNITION; COMPLEMENTARY THERAPIES; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PAIN; POSTMENOPAUSE; QUALITY OF LIFE; TREATMENT FAILURE;

EID: 22244441097     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sephton SE, Studts JL, Hoover K, et al. Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 2003;22:592-7.
2. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003;48:1420-9.
3. Dessein PH, Shipton EA, Stanwix AE, Joffe BI. Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm? Pain 2000;86:213-5.
4. Adler GK, Manfredsdottir VF, Creskoff KW. Neuroendocrine abnormalities in fibromyalgia. Curr Pain Headache Rep 2002;6:289-98.
5. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 1996;9:13-7.
6. Poyhia R, Da Costa D, Fitzcharles MA. Pain and pain relief in fibromyalgia patients followed for three years. Arthritis Rheum 2001;45:355-61.
7. Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208-17.
8. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-20.
9. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:2924-7.
10. Petri MA, Lahita RG, Van Vollenhoven RF, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002;46:1820-9.
11. Larkin M. DHEA: will science confirm the headlines? Lancet 1998;352:208.
12. Huppert FA, Van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst Rev 2001:CD000304.
13. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92.
14. Ferraccioli G, Cavalieri F, Salaffi F, et al. Neuroendocrinologic findings in primary fibromyalgia and in other chronic rheumatic conditions. J Rheumatol 1990;17:869-73.
15. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997;40:1928-39.
16. Dessein PH, Shipton EA, Joffe BI, Hadebe DP, Stanwix AE, Van der Merwe BA. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 1999;83:313-9.
17. Margaux J, Gervy C, De Maertelaer V, Gangji V, Steinfeld S, Appelboom T. Low serum concentrations of DHEA sulphate in fibromyalgia [abstract]. Arthritis Rheum 2001;44 Suppl:S70.
18. Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999;106:534-43.
19. Kaganov Y, Gattas N, Rimon D. Fibromyalgia-like syndrome secondary to Addison's disease. J Clin Rheumatol 2000;6:27-9.
20. Lichten M. Fibromyalgia: New treatments with DHEA, and growth hormone may bring improvement! [Internet] [cited 2005 Mar 02]. Available from: http://www.usdoctor.com/fibro.htm
21. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
22. Arlt W, Justl HG, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998;83:1928-34.
23. Finckh A, Morabia A, Deluze C, Vischer T. Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome. Arthritis Care Res 1998;11:116-23.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
25. Wolfe F, Hawley DJ, Goldenberg DL, Russell O, Buskila D, Neumann L. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 2000;27:1989-99.
26. Poitrenaud J, Israël L, Kozarevic D. Factorial structure and empirical validity of a shortened french version of the McNair and Khan' Scale on cognitive difficulties in activities of daily living. In. Beregi E, Gergely IA, Rajczi K, editors. Proceedings of the XVth Congress of the International Association of Gerontology 1993, July 4-9; Budapest. Bologna: Monduzzi; 1993.
27. Littlejohn GO. A database for fibromyalgia. Rheum Dis Clin North Am 1995;21:527-57.
28. McCoy N, Matyas R. McCoy female sexuality questionnaire. In: Davis CM, editor. Handbook of sexuality-related measures. Thousand Oaks: Sage; 1998:249-50.
29. Wechsler D: Wechsler Memory Scale - revised. New York, Psychological Corporation/Harcourt Brace Jovanovich, 1987.
30. Grace GM, Nielson WR, Hopkins M, Berg MA. Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 1999;21:477-87.
31. Cedraschi C, Desmeules J, Rapiti E, et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self-management. Ann Rheum Dis 2004;63:290-6.
32. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 1992;305:1249-52.
33. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression analysis and other multivariable methods. Pacific Grove: Duxbury Press; 1998.
34. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products [letter]. JAMA 1998;280:1565.
35. Skolnick AA. Scientific verdict still out on DHEA. JAMA 1996;276:1365-7.